Current
3.9×
5-Year Average
4.9×
All-Time High
6.8×
All-Time Low
1.3×
P/S Ratio daily chart for Thermo Fisher Scientific (TMO)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Thermo Fisher Scientific (TMO) from 2001 to 2025
| 2025 | $217.87B | $44.56B | 4.9× | +0.2× | |
| 2024 | $199.17B | $42.88B | 4.6× | -0.1× | |
| 2023 | $205.42B | $42.86B | 4.8× | -0.0× | |
| 2022 | $215.32B | $44.91B | 4.8× | -1.9× | |
| 2021 | $262.89B | $39.21B | 6.7× | +1.0× | |
| 2020 | $184.91B | $32.22B | 5.7× | +0.7× | |
| 2019 | $129.62B | $25.54B | 5.1× | +1.4× | |
| 2018 | $89.96B | $24.36B | 3.7× | +0.1× | |
| 2017 | $76.14B | $20.92B | 3.6× | +0.6× | |
| 2016 | $55.68B | $18.27B | 3.0× | -0.3× | |
| 2015 | $56.67B | $16.97B | 3.3× | +0.4× | |
| 2014 | $49.84B | $16.89B | 3.0× | -0.1× | |
| 2013 | $40.29B | $13.09B | 3.1× | +1.3× | |
| 2012 | $22.84B | $12.55B | 1.8× | +0.4× | |
| 2011 | $16.79B | $11.73B | 1.4× | -0.6× | |
| 2010 | $21.51B | $10.79B | 2.0× | +0.1× | |
| 2009 | $19.53B | $10.11B | 1.9× | +0.6× | |
| 2008 | $14.23B | $10.50B | 1.4× | -1.1× | |
| 2007 | $24.08B | $9.75B | 2.5× | -2.5× | |
| 2006 | $19.03B | $3.79B | 5.0× | +3.2× | |
| 2005 | $4.91B | $2.63B | 1.9× | -0.3× | |
| 2004 | $4.86B | $2.26B | 2.1× | +0.2× | |
| 2003 | $4.16B | $2.10B | 2.0× | +0.4× | |
| 2002 | $3.28B | $2.09B | 1.6× | -0.3× | |
| 2001 | $4.16B | $2.19B | 1.9× | — |
- 20254.9×
- 20244.6×
- 20234.8×
- 20224.8×
- 20216.7×
- 20205.7×
- 20195.1×
- 20183.7×
- 20173.6×
- 20163.0×
- 20153.3×
- 20143.0×
- 20133.1×
- 20121.8×
- 20111.4×
- 20102.0×
- 20091.9×
- 20081.4×
- 20072.5×
- 20065.0×
- 20051.9×
- 20042.1×
- 20032.0×
- 20021.6×
- 20011.9×
About P/S Ratio at Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific (TMO) P/S ratio is 3.9× as of June 5, 2026. The 5-year average is 4.9×. The sector median currently stands at 3.5×. The current ratio is at the 7th percentile of its own 10-year history.
Thermo Fisher Scientific (TMO) historical P/S ratio has ranged from a low of 1.3× (2002) to a high of 6.8× (2021) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Thermo Fisher Scientific P/S Ratio by Year
Thermo Fisher Scientific P/S Ratio 2025: 4.9×
Thermo Fisher Scientific (TMO) P/S ratio in 2025 was 4.9×, expanded from 4.6× the prior year.
Thermo Fisher Scientific P/S Ratio 2024: 4.6×
Thermo Fisher Scientific (TMO) P/S ratio in 2024 was 4.6×, contracted from 4.8× the prior year.
Thermo Fisher Scientific P/S Ratio 2023: 4.8×
Thermo Fisher Scientific (TMO) P/S ratio in 2023 was 4.8×, contracted from 4.8× the prior year.
Thermo Fisher Scientific P/S Ratio 2022: 4.8×
Thermo Fisher Scientific (TMO) P/S ratio in 2022 was 4.8×, contracted from 6.7× the prior year.
Thermo Fisher Scientific P/S Ratio 2021: 6.7×
Thermo Fisher Scientific (TMO) P/S ratio in 2021 was 6.7×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by P/S ratio.
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric